Log In Sign up
The largest database of trusted experimental protocols

Anti cys no antibody

Manufactured by Merck Group
Visit Supplier
Sourced in United States

The Anti-Cys NO antibody is a laboratory reagent used in research applications. It is designed to detect and measure the presence of cysteine-nitrosothiols (Cys-NO), which are important post-translational modifications involved in cellular signaling and homeostasis. The antibody can be utilized in various research techniques, such as Western blotting, immunohistochemistry, and enzyme-linked immunosorbent assays (ELISA), to study the role of Cys-NO in different biological systems.

Automatically generated - may contain errors

Lab products found in correlation

Anti nox4, by Abcam (3 mentions) Anti calstabin antibody, by Santa Cruz Biotechnology (3 mentions) Anti smad3, by Abcam (3 mentions) Anti p smad3, by Abcam (3 mentions) Anti ryr, by Thermo Fisher Scientific (3 mentions) Zoledronic acid zometa, by Novartis (2 mentions) Anti tgf β antibody clone 1d11.16.8 1d11, by BioXCell (2 mentions) Mouse igg1 isotype control mopc 21 unknown specificity, by BioXCell (2 mentions) Anti dnp, by Merck Group (2 mentions) Fura red, by Thermo Fisher Scientific (2 mentions) Recombinant human tgf β1, by R&D Systems (2 mentions) Anti tubulin, by Merck Group (2 mentions) Fluo 4 am, by Thermo Fisher Scientific (2 mentions) Anti gapdh, by Merck Group (2 mentions)

3 protocols using anti cys no antibody

1

Antibody Assay for RyR, Cys-NO, Calstabin, and Oxidative Stress Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies: Anti-RyR (Affinity Bioreagents, cat. no. MA3-916, Golden, CO, USA; 1:2,000), Anti-RyR1 5029 (custom rabbit polyclonal antibody raised against the C-terminus of human RyR1, Yenzyme, South San Francisco, CA, USA; 1:250 for IP), anti-Cys NO antibody (Sigma, cat. no. N0409, St. Louis, MO, USA; 1:2,000), anti-calstabin antibody (Santa Cruz Biotechnology, cat. no. sc-6173, Santa Cruz, CA, USA, 1:2,500), anti-DNP (Oxyblot, cat. no. S7150, Millipore, Darmstadt, Germany; 1:250), anti-pSMAD3 (Abcam, cat. no. ab40854, Cambridge, UK; 1:1,000), anti-SMAD3 (Abcam, cat. no. 52903, Cambridge, UK; 1:1,1000), and anti-Nox4 (Abcam, cat. no. 109225, Cambridge, UK; 1:1,000).
Regan J.N., Mikesell C., Reiken S., Xu H., Marks A.R., Mohammad K.S., Guise T.A, & Waning D.L. (2017). Osteolytic Breast Cancer Causes Skeletal Muscle Weakness in an Immunocompetent Syngeneic Mouse Model. Frontiers in Endocrinology, 8, 358.
+ Open protocol
+ Expand
2

Investigating TGF-β1 Signaling Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant human TGF-β1 was purchased from R&D Systems. SD-208 was obtained from Epichem Pty Ltd (Bentley, WA). Zoledronic acid (Zometa) was obtained from Novartis (Cambridge, MA). Rycal S107 (S107-HCl, FW 245.77) was synthesized as previously described17 (link),37 (link). Anti-TGF-β antibody clone 1D11.16.8 (1D11) and mouse IgG1 isotype control (MOPC-21; unknown specificity) were obtained from BioXCell (West Lebanon, NH). Nox4 inhibitor (GKT137831) was obtained from Ark Pharm, Inc. (Libertyville, IL). Antibodies: Anti-RyR (Affinity Bioreagents, cat. MA3-916, Golden, CO; 1:2,000), anti-Cys NO antibody (Sigma, cat. N0409, St. Louis, MO; 1:2,000), anti-calstabin antibody (Santa Cruz Biotechnology, cat. sc-6173, Santa Cruz, CA; 1:2,500), anti-DNP (Oxyblot, Millipore, Darmstadt, Germany; 1:250), anti-pSMAD3 (Abcam, cat. ab40854, Cambridge, UK; 1:1000), anti-SMAD3 (Abcam, cat. 52903, Cambridge, UK; 1:1000), anti-Nox4 (Abcam, cat. 109225, Cambridge, UK; 1:1000), anti-GAPDH (Sigma, cat. G8795, St. Louis, MO; 1:500) and anti-tubulin (Sigma, cat. 8203, St. Louis, MO; 1:500 each). Fluo-4 AM and Fura-red were obtained from Invitrogen/Molecular probes (cat. F-14201 and cat. F-3020, Eugene, OR).
Waning D.L., Mohammad K.S., Reiken S., Xie W., Andersson D.C., John S., Chiechi A., Wright L.E., Umanskaya A., Niewolna M., Trivedi T., Charkhzarrin S., Khatiwada P., Wronska A., Haynes A., Benassi M.S., Witzmann F.A., Zhen G., Wang X., Cao X., Roodman G.D., Marks A.R, & Guise T.A. (2015). Excess TGF-β mediates muscle weakness associated with bone metastases in mice. Nature medicine, 21(11), 1262-1271.
+ Open protocol
+ Expand
3

Investigating TGF-β1 Signaling Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant human TGF-β1 was purchased from R&D Systems. SD-208 was obtained from Epichem Pty Ltd (Bentley, WA). Zoledronic acid (Zometa) was obtained from Novartis (Cambridge, MA). Rycal S107 (S107-HCl, FW 245.77) was synthesized as previously described17 (link),37 (link). Anti-TGF-β antibody clone 1D11.16.8 (1D11) and mouse IgG1 isotype control (MOPC-21; unknown specificity) were obtained from BioXCell (West Lebanon, NH). Nox4 inhibitor (GKT137831) was obtained from Ark Pharm, Inc. (Libertyville, IL). Antibodies: Anti-RyR (Affinity Bioreagents, cat. MA3-916, Golden, CO; 1:2,000), anti-Cys NO antibody (Sigma, cat. N0409, St. Louis, MO; 1:2,000), anti-calstabin antibody (Santa Cruz Biotechnology, cat. sc-6173, Santa Cruz, CA; 1:2,500), anti-DNP (Oxyblot, Millipore, Darmstadt, Germany; 1:250), anti-pSMAD3 (Abcam, cat. ab40854, Cambridge, UK; 1:1000), anti-SMAD3 (Abcam, cat. 52903, Cambridge, UK; 1:1000), anti-Nox4 (Abcam, cat. 109225, Cambridge, UK; 1:1000), anti-GAPDH (Sigma, cat. G8795, St. Louis, MO; 1:500) and anti-tubulin (Sigma, cat. 8203, St. Louis, MO; 1:500 each). Fluo-4 AM and Fura-red were obtained from Invitrogen/Molecular probes (cat. F-14201 and cat. F-3020, Eugene, OR).
Waning D.L., Mohammad K.S., Reiken S., Xie W., Andersson D.C., John S., Chiechi A., Wright L.E., Umanskaya A., Niewolna M., Trivedi T., Charkhzarrin S., Khatiwada P., Wronska A., Haynes A., Benassi M.S., Witzmann F.A., Zhen G., Wang X., Cao X., Roodman G.D., Marks A.R, & Guise T.A. (2015). Excess TGF-β mediates muscle weakness associated with bone metastases in mice. Nature medicine, 21(11), 1262-1271.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!